Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

  • Did you mean: may le (22 items)
1.

Studying treatment resistance in depression using patient derived neurons in vitro.

Vadodaria KC, Ji Y, Skime M, Paquola A, Nelson T, Hall-Flavin D, Fredlender C, Heard KJ, Deng Y, Le AT, Dave S, Fung L, Li X, Marchetto MC, Weinshilboum R, Gage FH.

Mol Psychiatry. 2019 Jun;24(6):775. doi: 10.1038/s41380-019-0424-2. No abstract available.

PMID:
31118486
2.

Altered serotonergic circuitry in SSRI-resistant major depressive disorder patient-derived neurons.

Vadodaria KC, Ji Y, Skime M, Paquola AC, Nelson T, Hall-Flavin D, Heard KJ, Fredlender C, Deng Y, Elkins J, Dani K, Le AT, Marchetto MC, Weinshilboum R, Gage FH.

Mol Psychiatry. 2019 Jun;24(6):808-818. doi: 10.1038/s41380-019-0377-5. Epub 2019 Mar 22.

PMID:
30903001
4.

Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons.

Vadodaria KC, Ji Y, Skime M, Paquola A, Nelson T, Hall-Flavin D, Fredlender C, Heard KJ, Deng Y, Le AT, Dave S, Fung L, Li X, Marchetto MC, Weinshilboum R, Gage FH.

Mol Psychiatry. 2019 Jun;24(6):795-807. doi: 10.1038/s41380-019-0363-y. Epub 2019 Jan 30.

PMID:
30700803
5.

Comparing postoperative voiding dysfunction after mid-urethral sling using either a Babcock or Kelly clamp tensioning technique.

Chang OH, Hacker MR, Rosenblatt PL, Neo D, Von Bargen E, Berrahou I, Le A, Lefevre R, Hota LS.

Int Urogynecol J. 2019 Feb;30(2):301-305. doi: 10.1007/s00192-018-3638-y. Epub 2018 Mar 29.

6.

Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA.

Cortes CJ, Miranda HC, Frankowski H, Batlevi Y, Young JE, Le A, Ivanov N, Sopher BL, Carromeu C, Muotri AR, Garden GA, La Spada AR.

Nat Neurosci. 2014 Sep;17(9):1180-9. doi: 10.1038/nn.3787. Epub 2014 Aug 10.

7.
8.

Gangliosides block Aggregatibacter Actinomycetemcomitans leukotoxin (LtxA)-mediated hemolysis.

Forman MS, Nishikubo JB, Han RK, Le A, Balashova NV, Kachlany SC.

Toxins (Basel). 2010 Dec;2(12):2824-36. doi: 10.3390/toxins2122824. Epub 2010 Dec 14.

9.

In vitro synergism between LFA-1 targeting leukotoxin (Leukothera™) and standard chemotherapeutic agents in leukemia cells.

Gupta A, Le A, Belinka BA, Kachlany SC.

Leuk Res. 2011 Nov;35(11):1498-505. doi: 10.1016/j.leukres.2011.05.017. Epub 2011 Jun 12.

PMID:
21664691
10.

Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells.

Kachlany SC, Schwartz AB, Balashova NV, Hioe CE, Tuen M, Le A, Kaur M, Mei Y, Rao J.

Leuk Res. 2010 Jun;34(6):777-85. doi: 10.1016/j.leukres.2009.08.022. Epub 2009 Sep 10.

11.

Both leukotoxin and poly-N-acetylglucosamine surface polysaccharide protect Aggregatibacter actinomycetemcomitans cells from macrophage killing.

Venketaraman V, Lin AK, Le A, Kachlany SC, Connell ND, Kaplan JB.

Microb Pathog. 2008 Sep;45(3):173-80. doi: 10.1016/j.micpath.2008.05.007. Epub 2008 Jun 5.

12.

A bioluminescent HL-60 cell line to assay anti-leukaemia therapeutics under physiological conditions.

Isaza MP, Chau JT, Le A, Balashova NV, Patel JK, Salerno E, Crosby JA, O'Connor A, Kachlany SC.

Luminescence. 2008 Jan-Feb;23(1):17-21. doi: 10.1002/bio.1010.

PMID:
18167057
  • Did you mean: may le (22 items)

Supplemental Content

Loading ...
Support Center